Creating a pragmatic trials program for breast cancer patients: Rethinking Clinical Trials (REaCT).
Bassam BasulaimanArif Ali AwanDean FergussonLisa VandermeerAngel ArnaoutJohn HiltonBrian HuttonAnil Abraham JoyAndrew RobinsonNadia CalifarettiCarol StoberMarta SienkiewiczKednapa ThavornMark ClemonsPublished in: Breast cancer research and treatment (2019)
The REaCT program was developed to tackle important practice questions that will better guide optimal practice and to increase the availability of pragmatic clinical trials. While many challenges remain, future strategies will involve including more study sites and efforts to integrate novel information technology strategies.